Printing of individualized medicines is very interesting option for hospital pharmacists. Up to now those individualized medicines are often produced in the patient group of children. Dosages have to be adapted, alternative dosage forms have to be developed as many of those patients are not able to swallow tablets or capsules. Printing those medicines on orodispersable films with some kind of inkjet printer could be very helpful.
Continue reading “Printing of Medicines – What do Hospital Pharmacists expect from Hard- and Software Vendors”Bringing 3D printing to community pharmacy
Pharmacy compounding, local medicine production, close to the patient and adapted to individual needs, has been around for many decades but the techniques used have not changed much over the years. A more innovative option is the production of 3D printed tablets, and benchtop FDM printers would fit in any community or hospital pharmacy.
Continue reading “Bringing 3D printing to community pharmacy”GPP Support is content partner of the 3D Pharma Printing Conference
GPP Support and Jakajima, the organizer of the annual 3D Pharma Printing Conference, have agreed to work together regarding this conference, which will be held for the fifth time in 2022. The conference is part of the two day 3D Medical Printing Series.
Continue reading “GPP Support is content partner of the 3D Pharma Printing Conference”Additive manufacturing of “polypill” capsules of complex geometry with individualised release
A Presentation by Beatriz Pereira, Scientist, University of Central Lancashire
Polypharmacy is often needed for the management of chronic conditions and is usually associated with poor patient adherence. Therefore, easily personalised systems are necessary to accommodate complex therapeutic regimens.
Continue reading “Additive manufacturing of “polypill” capsules of complex geometry with individualised release”Enabling tomorrow’s medicine by means of 3D printing
presentation by Anton Aulbers, Senior Consultant 3D Pharma printing at TNO
Continue reading “Enabling tomorrow’s medicine by means of 3D printing”Additive Manufacturing: Unlocking Pharma’s Unmet Challenges
A presentation by Jae Yoo, CTO of Aprecia Pharmaceuticals. He is serving as Chief Technology Officer for Aprecia Pharmaceuticals, LLC since August 2018. His 3DP journey started at MIT in the early 1990’s where he developed and used an inkjet printing based 3DP process to fabricate advanced ceramic materials with compositional gradient.
Continue reading “Additive Manufacturing: Unlocking Pharma’s Unmet Challenges”Additive Manufacturing of Tablets
presentation by Christoph Hüls, Founder Additive Manufacturing of Tablets, Merck Innovation Center, Merck KGaA
Additive Manufacturing of Tablets has the potential to simplify the manufacturing of pills (tablets). Instead of a multistep complicated process, a three step process (mixing a powder formulation, printing the tablets in the printer and coating of the tablets) will lead to cost and time savings for customers.
Continue reading “Additive Manufacturing of Tablets”Challenges and opportunities of 3D-printed drugs for the hospital pharmacy
presentation by Josep M Guiu, Head of pharmaceutical planning and pharmacotherapy coordination at the Catalan Health and Social Care Consortium in Barcelona, Spain.
There is a huge potential of 3D printing to revolutionise clinical pharmacy practice with the development of a new generation of personalized compounded drugs. The implementation of a 3D printer into a hospital pharmacy could make possible to individualize shapes, sizes and dosages of several oral drugs to patients.
However, its implementation needs the collaboration of hospital pharmacists with pharmaceutical scientists and the pharmaceutical industry, as well as to define a new regulatory framework for these new drugs.
program: https://www.3dpharmaprintingconference.com/speakers/
Continue reading “Challenges and opportunities of 3D-printed drugs for the hospital pharmacy”Polar Printers – A New Approach
presentation by Carlo De Giorgi, CEO, Ulia Pharma
Is converting traditional 3D printing technologies to the pharmaceutical world really the solution? The innovative approach of the Ulia Pharma company aims to modify the current pharmaceutical production machinery to bring them closer to the world of 3d drugs.
Continue reading “Polar Printers – A New Approach”Use of 3D printing for therapy production in a clinical setting
presentation by Alvaro Goyanes, Co-founder and Director of Development, FabRX
3D printing (3DP) is an increasingly growing manufacturing technology that provides the ability to fabricate structures of precise geometries from a 3D model by deposition of many thin layers. 3DP is nowadays used as a production tool or for rapid prototyping in many areas.
Continue reading “Use of 3D printing for therapy production in a clinical setting”